Eli Lilly and Company opened the 11,500-sf Lilly Life Sciences Studio in San Diego in January of 2020. Part of a $90 million investment to expand the company's research footprint, the laboratory leverages a robotic cloud platform created by Strateos to enable other drug discovery companies and investigators to access the remote-controlled facility. The studio lab physically and virtually integrates all aspects of the drug discovery process into a fully automated platform, including design, synthesis, purification, analysis, sample management, and hypothesis testing. Research scientists can remotely control their experiments via a web-based interface, enabling studies to be run and refined in real time with a high degree of reproducibility. The project is located in the Lilly Biotechnology Center and will be operated by Strateos.